SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-3 - Registration statement under Securities Act of 1933:
SEC Accession No. 0001193125-20-321539
Filing Date
2020-12-18
Accepted
2020-12-18 16:33:23
Documents
10

Document Format Files

Seq Description Document Type Size
1 S-3 d73885ds3.htm S-3 455072
2 EX-1.2 d73885dex12.htm EX-1.2 200260
3 EX-4.3 d73885dex43.htm EX-4.3 298770
4 EX-4.5 d73885dex45.htm EX-4.5 98436
5 EX-4.6 d73885dex46.htm EX-4.6 99841
6 EX-4.7 d73885dex47.htm EX-4.7 88400
7 EX-5.1 d73885dex51.htm EX-5.1 31191
8 EX-23.1 d73885dex231.htm EX-23.1 1563
9 GRAPHIC g73885g94i97.jpg GRAPHIC 40273
10 GRAPHIC g73885snap0002.jpg GRAPHIC 3074
  Complete submission text file 0001193125-20-321539.txt   1328139
Mailing Address 2155 PARK BOULEVARD PALO ALTO CA 94306
Business Address 2155 PARK BOULEVARD PALO ALTO CA 94306 650-279-9845
Eiger BioPharmaceuticals, Inc. (Filer) CIK: 0001305253 (see all company filings)

IRS No.: 361004130 | Fiscal Year End: 1231
Type: S-3 | Act: 33 | File No.: 333-251497 | Film No.: 201401032
SIC: 2836 Biological Products, (No Diagnostic Substances)